Table 1.
Demographic and clinical variables of the study patients.
| Characteristics | Value |
|---|---|
| Total numbera | 201 |
| Mean age (years ± standard deviation)b | 52 ± 14 |
| Sex (male:female)a | 88:113 |
| Treatment stagea | |
| Pre-treatment | 65 (32.3) |
| Post-treatment | 136 (67.7) |
| Open surgery | 5 |
| TSA | 104 |
| Radiation therapy | 7 |
| Stereotactic radiosurgery | 20 |
| Tumour typea | |
| Non-functioning adenoma | 117 (58.2) |
| Functioning adenoma | 84 (41.8) |
| Prolactin | 58 |
| Growth hormone | 15 |
| ACTH | 11 |
| Median time between the initial surgery and MRI examination (months)c | 23 ± 82 |
TSA transsphenoidal surgery, ACTH adrenocorticotropic hormone, MRI magnetic resonance imaging.
aData are expressed as count, with percentage in parentheses.
bData are expressed as mean, with standard deviation.
cData are expressed as median, with interquartile range.